Cardiff investigates two cancer research professors for data manipulation
The Cardiff University in UK is now investigating two cancer researchers, both senior professors, for suspected scientific misconduct. The evidenceContinue Reading
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
The Cardiff University in UK is now investigating two cancer researchers, both senior professors, for suspected scientific misconduct. The evidenceContinue Reading
The European Union Commission staunchly refuses to tell me what exactly their funded scientists intend to do to the scheduledContinue Reading
The Science and Technology Committee of the British House of Commons is now dealing with the trachea transplants performed byContinue Reading
Before biology became digital, with its -omics and big data, there were mostly gels and microscopy images. The peak of image use in biomedical papers was reached at the turn of the century, those became the golden times of Photoshop-assisted data manipulation. To celebrate that period, I selected an example of the British cancer researcher Paul Workman, President and CEO of the huge Institute of Cancer Research (ICR) in London.
Swedish start-up Verigraft received €2.2 Million from European Union, to further develop regenerative medicine technology tainted by research misconduct and patient abuse. The founder of this very company: Suchitra Sumitran-Holgersson. A clinical trial is scheduled based on debunked science of recellurising dead blood vessel grafts.
On July 29th 2016, Journal of Biological Chemistry (JBC) retracted a cardiology paper from 2009 for data manipulations. Only someContinue Reading
Things are happening at the French state’s network of research institutes, Centre National de la Recherche Scientifique (CNRS). Their interim president,Continue Reading
I previously reported about numerous cases of suspected (or even blatantly obvious) data manipulation at the Weizmann Institute of ScienceContinue Reading
The following email exchange took place between the academic Editor-in-Chief of an Elsevier subscription journal and a professor of physics and astronomy, who was invited to peer review a clinical trial study on gestational diabetes, his expertise assumed from some obscure “keywords”.
“I fully support Dr Ashutosh Tiwari being permitted to enter the Docent programme of Linköping University. [.. }He is carrying out first-rate research, supervising students, has organised a number of international events on behalf of Linköping University, has an excellent publication record and has recently designed a PhD course for us. […]
Yours sincerely,
Professor Anthony P F Turner PhD, DSc, FRSC”









